Chongqing Genrix Biopharmaceutical Co., Ltd.SSE: 688443

Notice on Convening the 2nd Extraordinary General Meeting in 2026

· Issued by Chongqing Genrix Biopharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Shareholders will have the option to vote both in person and through an online voting system provided by the Shanghai Stock Exchange. The agenda includes several proposals related to the company's stock incentive plan, which have been approved by the board.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix

Earlier from Chongqing Genrix Biopharmaceutical

Later from Chongqing Genrix Biopharmaceutical

All Chongqing Genrix Biopharmaceutical news releases